HLB Pharmaceutical Co., Ltd (047920.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

39.2x

Market Cap

KRW 250.58B

MomentumView details →

1D Return

+3.66%

YTD Return

−50.94%

RSI (14)

47.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

39.2x

Market Cap

KRW 250.58B

RSI (14)

47.7

MomentumView details →

1D Return

+3.66%

YTD Return

−50.94%

ProfitabilityView details →

Gross Margin

44.77%

Net Margin

1.09%

EBITDA Margin

2.54%

ROE (TTM)

2.11%

ROA (TTM)

1.55%

Asset Turnover

1.32x

GrowthView details →

Revenue YoY

+68.61%

EPS YoY

−52.22%

FCF YoY

+11.06%

Revenue CAGR 3Y

+24.13%

EPS CAGR 3Y

+120.40%

EBITDA YoY

−35.74%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

1.88x

Quick Ratio

1.14x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

251.95B

Net Income (TTM)

2.76B

Op. CF (TTM)

4.33B

Latest newsMore news →

HLB, SPG, and Peptron each surged more than 50% over the past month on the KOSDAQ.24d ago

Similar companies

Huons Co., Ltd.243070.KQ Suheung Co., Ltd.008490.KS Samjin Pharmaceuticals Co., Ltd.005500.KS Ilsung Is Co., Ltd.003120.KS Hansoh Pharmaceutical Group Company Limited03692.HK JW Holdings Corporation096760.KS Find similar companies →

Latest newsMore news →

HLB, SPG, and Peptron each surged more than 50% over the past month on the KOSDAQ.24d ago